Lupin Pharmaceuticals Inc. recalls
6 recalls filed under Lupin Pharmaceuticals Inc.. The most recent was published September 2, 2026.
-
Class II · last month
Lupin Pharmaceuticals Inc. Clobetasol Propionate Cream USP, 0.05%, 60 g tube recall: Failed content uniformity specifications
Failed content uniformity specifications.
-
Class II · 4 months ago
Lupin Pharmaceuticals Inc. prednisoLONE Acetate Ophthalmic Suspension, USP, 1% recall: Presence of Foreign Substance
Presence of Foreign Substance
-
Class II · 4 months ago
Lupin Pharmaceuticals Inc. Glucagon Emergency Kit for Low Blood Sugar recall: CGMP deviation: OOS result observed for the Gliding Force functionality test
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
-
Class II · 5 months ago
Lupin Pharmaceuticals Inc. Liraglutide Injection, 18 mg/3 mL recall: Presence of particulate matter: a white thread-like structure in the cartridge
Presence of particulate matter: a white thread-like structure in the cartridge
-
Class II · 10 months ago
Lupin Pharmaceuticals Inc. Sertraline Hydrochloride Tablets USP, 100 mg recall: Defective container - seal not adhering to bottles
Defective container - seal not adhering to bottles
-
Class II · 10 months ago
Lupin Pharmaceuticals Inc. Ganirelix Acetate Injection, 250 mcg/0.5mL recall: Failed impurities/degradation specifications: out of specification results
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
About this page
Lupin Pharmaceuticals Inc. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.